It was reported that via journal article: title: results from a prospective, multicenter study of reflux management with the linx system for gastroesophageal reflux disease after laparoscopic sleeve gastrectomy.Author(s) : william petraiuolo blue ash oh1 , leena khaitan chardon oh2 , michael hill saranac lake ny3 , michael michel summerville sc4 , patrick m chiasson md tucson az5 , philip woodworth lone tree co6 , reginald bell englewood co7 , carlos anciano greenville nc8 , ragui sadek somerset nj9 , aaron hoffman 1.Citation: 2022 abstracts 38th annual meeting of the american society for metabolic and bariatric surgery / surgery for obesity and related diseases 18 (2022) s1¿s89.The aim of this study is to confirm safety and efficacy of linx after laparoscopic sleeve gastrectomy.Patients had linx implantation were followed 12-months post-implant are involved in this study.Reported complications: (n=15) device-related and/or procedure-related adverse events including (n=2) who had dysphagia and pain which resolved without sequelae, (n=2) underwent explant.Conclusion: linx safety was confirmed post-lsg with an overall improvement of gerd symptoms and reduction in ppi use with explants within anticipated range.
|
(b)(4).Date sent: 8/9/2023.B3: only event year known: 2022.This report is related to a journal article, therefore no product will be returned for analysis and the batch history records cannot be reviewed as the lot/batch number has not been provided.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|